Pain, Inflammation, and Cannabis in HIV
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HIV Infections
- Neuropathic Pain
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This study will test how research vouchers for medical cannabis use affects neuropathic pain in PLWH with neuropathic pain. PITCH is a 2-arm randomized trial in which 100 adult PLWH with neuropathic pain and medical cannabis certification in New York State are randomized 1:1 to 1) vouchers for high ...
This study will test how research vouchers for medical cannabis use affects neuropathic pain in PLWH with neuropathic pain. PITCH is a 2-arm randomized trial in which 100 adult PLWH with neuropathic pain and medical cannabis certification in New York State are randomized 1:1 to 1) vouchers for high delta-9-tetrahydrocannabinol (THC) capsules (4.3 mg THC/0.7 mg CBD soft-gel capsules), or 2) vouchers for high cannabidiol (CBD) capsules (0.2 mg THC/4.8 mg CBD soft-gel capsules). Over 14 weeks, participants will have 5 in-person visits and 15 web- or phone-based questionnaires. Data sources will be blood samples, questionnaires, and medical and pharmacy records.
Tracking Information
- NCT #
- NCT04860089
- Collaborators
- National Institute on Drug Abuse (NIDA)
- University of Colorado, Boulder
- University of Pittsburgh
- Vireo Health
- Investigators
- Principal Investigator: Deepika E Slawek, MD, MPH, MS Montefiore Medical Center
Get Well Soon